StatPearls, LLC

  • Heart Failure
  • Hypertension
  • Myocardial Ischemia
  • Renal Insufficiency, Chronic

Olmesartan

Olmesartan is a medication used in the management of hypertension. It is in the angiotensin receptor blocking (ARB) class of drugs. Olmesartan, like other ARBs, can be used as monotherapy for hypertension in the absence of comorbidities such as chronic kidney disease, cerebrovascular events, heart failure, diabetes, and ischemic heart disease. ARBs have been a recommendation to help lower microalbuminuria in patients with diabetes mellitus and can also lower cardiovascular events and mortality in ischemic heart disease in clinical practice. This activity reviews the indications, mechanism, pharmacokinetics, adverse drug reactions, toxicity, warning, precautions, and contraindications for olmesartan as a valuable agent in managing patients suffering from hypertension.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

IPCE CreditsUp to 1.5 creditsAAPA Category 1 Credit™Up to 1.5 creditsAMA PRA Category 1 Credit™Up to 1.5 creditsNursingUp to 1.5 creditsPharmacyUp to 1.5 credits

MOC types

ABS — Accredited CMEUp to 1.5 pointsABPATH — Lifelong LearningUp to 1.5 pointsABA — Lifelong LearningUp to 1.5 pointsABTS — Accredited CMEUp to 1.5 pointsABIM — Medical KnowledgeUp to 1.5 pointsABS — Self-AssessmentUp to 1.5 pointsABP — Lifelong Learning and Self-AssessmentUp to 1.5 pointsABTS — Self-AssessmentUp to 1.5 points

FDA REMS

No

Qualifies for MIPS

No

Target Specialties

Cross-Specialty

Relevant across 10 specialties.

Pricing

Fee varies

This provider typically $49–98

See fees on statpearls.com

Listed by the provider

  • Article / monograph / reference
  • Credit · Up to 1.5 credits
  • MOC · Up to 1.5 points
  • Fee varies · this provider typically $49–98
  • Released
    Sep 1, 2026
  • Last day to claim credit
    Sep 1, 2029 3 years left